0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

NDDS in Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

NDDS in Cancer Therapy - Global Strategic Business Report

  • Report
  • June 2025
  • 196 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • June 2025
  • 194 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Liver Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 277 Pages
  • Global
From
EUR$5,850USDGBP
Lymphoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lymphoma Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 406 Pages
  • Global
From
EUR$5,850USDGBP
Melanoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Melanoma Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 162 Pages
  • Global
From
EUR$5,850USDGBP
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 151 Pages
  • Global
From
EUR$5,850USDGBP
Kidney Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 148 Pages
  • Global
From
EUR$5,850USDGBP
Apoptosis - Global Strategic Business Report - Product Thumbnail Image

Apoptosis - Global Strategic Business Report

  • Report
  • June 2025
  • 72 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Antibody Fragments - Global Strategic Business Report - Product Thumbnail Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • June 2025
  • 176 Pages
  • Global
From
EUR$5,850USDGBP
PARP Inhibitor Biomarkers - Global Strategic Business Report - Product Thumbnail Image

PARP Inhibitor Biomarkers - Global Strategic Business Report

  • Report
  • June 2025
  • 278 Pages
  • Global
From
EUR$5,850USDGBP
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
EUR$5,850USDGBP
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more